No Data
No Data
Top Midday Gainers
HC Wainwright & Co. Reiterates Buy on TransCode Therapeutics, Maintains $20 Price Target
H.C. Wainwright Maintains Transcode Therapeutics(RNAZ.US) With Buy Rating, Maintains Target Price $20
TransCode Therapeutics Shares Are Trading Higher After the Company Announced the Completion of Its Cohort 3 Initial Dosing for Its Phase 1 Trial of TTX-MC138.
TransCode Therapeutics Announces Completion of Cohort 3 Initial Dosing With Lead Candidate in Phase 1 Clinical Trial
Trending Stocks Today | Transcode Therapeutics Surges 50.89%
Unlock the Full List
iluvpoptarts : ty much. I owe you a good joke when you're ready
manukahoney : when will CCTG pump occur? pre market today?
Jaguar8 OP manukahoney : it already started pumping Friday AH
manukahoney Jaguar8 OP : is it too late if i pump today during pre market sir?